What are the risks and recommended management if a thyroid shield is applied to the genital area during radiology procedures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immediate Action Required: Remove and Replace the Shield

If a thyroid shield is mistakenly placed on the genital area during radiology procedures, it should be immediately removed and replaced with appropriate gonadal shielding (if indicated), as thyroid shields are not designed for genital protection and may provide inadequate coverage, incorrect positioning, or potential contamination risk.

Understanding the Error

This represents a fundamental equipment misuse error. Thyroid shields are specifically designed to protect the thyroid gland and cervical bone marrow during fluoroscopic procedures 1, 2, 3. They are typically worn as collars around the neck and provide approximately 0.25-0.5 mm lead equivalent protection 2, 3.

Key Problems with This Misapplication

Inadequate Protection:

  • Thyroid shields are shaped and sized for neck anatomy, not pelvic/genital anatomy
  • May not provide complete coverage of gonadal tissue
  • Positioning will be suboptimal and unstable

Contamination Risk:

  • Thyroid shields worn in operating rooms are frequently contaminated with bacteria, with 81% growing coagulase-negative staphylococcus in one study 4
  • Using contaminated equipment near the genital area poses infection risk

Current Evidence on Gonadal Shielding: The practice of routine gonadal shielding itself is now controversial. Major organizations including the American Association of Physicists in Medicine (AAPM) and British Institute of Radiology (BIR) have recommended discontinuing routine gonadal shielding 5, 6, 7. The rationale includes:

  • Modern digital imaging delivers substantially lower radiation doses
  • Shields may obscure critical anatomy requiring repeat imaging
  • Automatic exposure control systems may paradoxically increase radiation dose when shields are detected in the field 6, 7
  • Inaccurate shield placement (particularly in females) is common, with females significantly more likely to have shields placed incorrectly (OR 1.38,95% CI 0.88-1.87, p<0.001) 5

Proper Management Algorithm

Step 1: Immediate Recognition and Correction

  • Stop the procedure if not yet started
  • Remove the thyroid shield from the genital area
  • Clean the area if there was direct contact

Step 2: Assess Need for Gonadal Protection

For cardiac/thoracic procedures (where gonads are not in primary beam):

  • Gonadal shielding is generally NOT needed 8
  • Scatter radiation to gonads is minimal and external shielding provides no benefit 8
  • Focus on collimation and minimizing fluoroscopy time instead

For pelvic procedures (where gonads are in primary beam):

  • Consider patient-specific factors:
    • Reproductive age and plans for conception 8
    • Gender (males may benefit more than females from accurate shielding) 5
    • Examination type and anatomy of interest 9

Step 3: If Shielding is Deemed Appropriate

  • Use proper gonadal contact shields (flat contact shields for males show 36.4% dose reduction) 10
  • Ensure accurate placement to avoid obscuring anatomy
  • Verify shield position does not interfere with automatic exposure control
  • Document decision-making process

Step 4: Alternative Protection Strategies Rather than relying on shields, prioritize:

  • Tight collimation to area of interest 8, 2
  • Minimize fluoroscopy time - use only during actual catheter manipulation 2, 3
  • Optimize table and detector positioning 2, 3
  • Use lowest appropriate pulse rates 2, 3
  • Employ "last image hold" to avoid additional exposures 2, 3

Special Populations

Pregnant Patients:

  • Procedures involving head or chest do not necessarily deliver dangerous doses to the conceptus 8
  • Fetal dose should be estimated by a health physicist 11
  • Maternal survival takes priority; provide same supportive care as non-pregnant patients 11

Pediatric Patients:

  • Children are 10-30 times more radiosensitive than adults 8
  • Focus on protocol optimization rather than shielding 7
  • If shielding used, accuracy is critical (particularly challenging in females) 5

Reproductive-Age Adults:

  • Risk of heritable effects is approximately 0.01% per 10 mGy gonadal dose 8
  • Advise waiting 6 months after gonadal doses exceeding 100 mGy before attempting conception 8

Common Pitfalls to Avoid

  1. Do not assume all shields are interchangeable - each type serves a specific anatomical purpose
  2. Do not use contaminated equipment near sterile or sensitive areas
  3. Do not rely solely on shielding when technique optimization is more effective
  4. Do not shield reflexively without considering modern guidelines and potential harms
  5. Do not place shields where they may trigger automatic exposure control to increase dose

Documentation and Follow-Up

  • Document the error and corrective action taken
  • Report as a safety event per institutional protocol
  • Provide radiation safety re-education to involved staff
  • Review institutional shielding policies against current evidence 6, 7

The fundamental principle remains ALARA (As Low As Reasonably Achievable), but this is now best achieved through justification and protocol optimization rather than routine patient shielding 7.

References

Research

Potential infection risk from thyroid radiation protection.

Journal of orthopaedic trauma, 2015

Research

[The End of Patient Shielding: Rationale for Discontinuing the Practice].

Journal of the Korean Society of Radiology, 2025

Research

Gonadal Shielding in Radiography: A Best Practice?

Radiologic technology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.